These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3537288)

  • 1. Does dimethicone increase the efficacy of antacids in the treatment of reflux oesophagitis?
    Ogilvie AL; Atkinson M
    J R Soc Med; 1986 Oct; 79(10):584-7. PubMed ID: 3537288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of a dimethicone/antacid (Asilone gel) with an alginate/antacid (Gaviscon liquid) in the management of reflux oesophagitis.
    Smart HL; Atkinson M
    J R Soc Med; 1990 Sep; 83(9):554-6. PubMed ID: 2213800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antacids and cimetidine treatment for gastro-oesophageal reflux and peptic oesophagitis.
    Cucchiara S; Staiano A; Romaniello G; Capobianco S; Auricchio S
    Arch Dis Child; 1984 Sep; 59(9):842-7. PubMed ID: 6385868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind clinical, endoscopic and histological comparison of hydrotalcite/dimethicone suspension and magnesium hydroxide/aluminum hydroxide suspension in the treatment of symptomatic gastritis.
    Cobden I; McMahon MJ; Dixon MF; Axon AT
    Pharmatherapeutica; 1981; 2(9):607-12. PubMed ID: 7267678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptomatic effect of a low-dose antacid regimen in reflux oesophagitis.
    Weberg R; Berstad A
    Scand J Gastroenterol; 1989 May; 24(4):401-6. PubMed ID: 2675302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind comparison of liquid antacid and placebo in the treatment of symptomatic reflux esophagitis.
    Graham DY; Patterson DJ
    Dig Dis Sci; 1983 Jun; 28(6):559-63. PubMed ID: 6345111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cimetidine in symptomatic gastro-oesophageal reflux.
    Powell-Jackson P; Barkley H; Northfield TC
    Lancet; 1978 Nov; 2(8099):1068-9. PubMed ID: 82086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoscopically controlled trial of alginate and antacid in reflux oesophagitis.
    Scobie BA
    Med J Aust; 1976 Apr; 1(17):627-8. PubMed ID: 778564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ranitidine in reflux oesophagitis. A double-blind placebo-controlled study.
    Hine KR; Holmes GK; Melikian V; Lucey M; Fairclough PD
    Digestion; 1984; 29(2):119-23. PubMed ID: 6329862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of activated dimethicone and a proprietary antacid preparation containing this agent on the absorption of phenytoin.
    McElnay JC; Uprichard G; Collier PS
    Br J Clin Pharmacol; 1982 Apr; 13(4):501-5. PubMed ID: 7066165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of reflux esophagitis with antacids].
    Weihrauch TR
    Z Gastroenterol; 1983 Mar; 21 Suppl():50-2. PubMed ID: 6344504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cimetidine versus antacid in scleroderma with reflux esophagitis. A randomized double-blind controlled study.
    Petrokubi RJ; Jeffries GH
    Gastroenterology; 1979 Oct; 77(4 Pt 1):691-5. PubMed ID: 381093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term treatment of reflux oesophagitis with ranitidine 300 mg nocte. Italian multicentre study.
    Bovero E; Cheli R; Barbara L; Baldi F; Boero A; Mura GC; Camarri E; Corradini P; Dobrilla G; Piazzi L
    Hepatogastroenterology; 1987 Aug; 34(4):155-9. PubMed ID: 3311954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ranitidine and high-dose antacid in reflux oesophagitis. A randomized, placebo-controlled trial.
    Grove O; Bekker C; Jeppe-Hansen MG; Karstoft E; Sanchez G; Axelsson CK; Nielsen HO; Andersen B; Rask-Madsen J
    Scand J Gastroenterol; 1985 May; 20(4):457-61. PubMed ID: 3895381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sucralfate and alginate/antacid in reflux esophagitis.
    Laitinen S; Ståhlberg M; Kairaluoma MI; Kiviniemi H; Pääkkönen M; Lahtinen J; Poikolainen E; Aukee S
    Scand J Gastroenterol; 1985 Mar; 20(2):229-32. PubMed ID: 2986275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of childhood peptic oesophagitis with famotidine or alginate-antacid.
    Oderda G; Dell'Olio D; Forni M; Farina L; Tavassoli K; Ansaldi N
    Ital J Gastroenterol; 1990 Dec; 22(6):346-9. PubMed ID: 2131953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why do apparently healthy people use antacid tablets?
    Graham DY; Smith JL; Patterson DJ
    Am J Gastroenterol; 1983 May; 78(5):257-60. PubMed ID: 6846300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of reflux esophagitis with H2-blockers, antacids and prokinetic drugs. An analysis of randomized clinical trials.
    Koelz HR
    Scand J Gastroenterol Suppl; 1989; 156():25-36. PubMed ID: 2568015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Open safety-in-use trial of a new high-potency antacid product.
    Pawlowski GJ; Krondl A; Darke AC
    J Int Med Res; 1983; 11(4):239-42. PubMed ID: 6617982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of Algicon, an antacid-alginate preparation, in patients with reflux oesophagitis.
    Maxton DG; Miller JP; Whorwell PJ; Butler JK
    Br J Clin Pract; 1988 Sep; 42(9):368-71. PubMed ID: 3075928
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.